Association of high CD4-positive T cell infiltration with mutations in HLA class II-regulatory genes in microsatellite-unstable colorectal cancer

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  2015-02-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00262-014-1638-4PMID 25445815PMCID PMC8711774
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Infiltration of Lynch Colorectal Cancers by Activated Immune Cells Associates with Early Staging of the Primary Tumor and Absence of Lymph Node Metastases

  2012cited by this paper
• Immune evasion of microsatellite unstable colorectal cancers

  2010cited by this paper
• Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma

  2010cited by this paper
• Lack of HLA class II antigen expression in microsatellite unstable colorectal carcinomas is caused by mutations in HLA class II regulatory genes

  2010influential reference
• Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts

  2010cited by this paper
• Microsatellite instability in colorectal cancer.

  2010cited by this paper
• SelTarbase, a database of human mononucleotide-microsatellite mutations and their potential impact to tumorigenesis and immunology

  2009cited by this paper
• HLA‐DR expression is associated with better prognosis in sporadic Australian clinicopathological Stage C colorectal cancers

  2009cited by this paper
• HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance

  2008cited by this paper
• Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers.

  2008cited by this paper
• High density of FOXP3-positive T cells infiltrating colorectal cancers with microsatellite instability

  2008cited by this paper
• Beta2‐microglobulin mutations in microsatellite unstable colorectal tumors

  2007cited by this paper
• A fresh look at an old story: revisiting HLA class II antigen expression by melanoma cells

  2006cited by this paper
• Microsatellite instability in the development of DNA mismatch repair deficient tumors

  2006influential reference
• Intratumoral T-cell infiltrates and MHC class I expression in patients with stage IV melanoma.

  2005cited by this paper
• T25 repeat in the 3' untranslated region of the CASP2 gene: a sensitive and specific marker for microsatellite instability in colorectal cancer.

  2005cited by this paper
• Molecular testing for microsatellite instability and its value in tumor characterization

  2005cited by this paper
• Microsatellite instability in colorectal cancer is associated with local lymphocyte infiltration and low frequency of distant metastases

  2005cited by this paper
• Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-γ-induced HLA-DR expression in colorectal and gastric cancer cells

  2004cited by this paper
• Mini‐review: Specificity and expression of CIITA, the master regulator of MHC class II genes

  2004cited by this paper
• Strong HLA-DR expression in microsatellite stable carcinomas of the large bowel is associated with good prognosis

  2002cited by this paper
• Frameshift peptide‐derived T‐cell epitopes: A source of novel tumor‐specific antigens

  2001cited by this paper
• Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer

  2001cited by this paper
• Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages.

  1999cited by this paper
• High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability.

  1999cited by this paper
• Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma.

  1998cited by this paper
• A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

  1998cited by this paper
• Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism.

  1996cited by this paper
• Biological Implications of HLA‐DR Expression in Tumours

  1995cited by this paper
• Immunohistochemically demonstrated expression of HLA‐DR antigen in colorectal adenocarcinomas and its relation to clinicopathological features

  1995cited by this paper
• Characterization of anti-HLA class II monoclonal antibody LGII-612.14 reacting with formalin fixed tissues.

  1993cited by this paper
• Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis

  1993cited by this paper
• Microsatellite instability in cancer of the proximal colon.

  1993cited by this paper
• Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.

  1990cited by this paper
• Purification of Murine IgG Monoclonal Antibodies by Precipitation with Caprylic Acid: Comparison with Other Methods of Purification

  1989cited by this paper
• Class I and II HLA antigen distribution in normal mucosa, adenoma and colon carcinoma: relation with malignancy and invasiveness.

  1987cited by this paper
• Anti-Leu-3/T4 antibodies react with cells of monocyte/macrophage and Langerhans lineage.

  1983cited by this paper

• Spontaneous Regression of Advanced Transverse Colon Cancer: A Case Report

  2025cites this paper
• Multi-omics analyses inform mechanisms of immunotherapy response in pancreatic cancer

  2025cites this paper
• Immunogenomic classification and nomogram development and validation for colorectal cancer survival prediction based on immune-related genes

  2025cites this paper
• RFX5 promotes the progression of triple-negative breast cancer through transcriptional activation of JAG1

  2025cites this paper
• A case of multiple advanced colon cancers with spontaneous regression of only one lesion after biopsy: a case report and literature review

  2025cites this paper
• MAP1LC3C repression reduces CIITA- and HLA class II expression in non-small cell lung cancer

  2025cites this paper
• Prognostic value of four immune-related genes in lower-grade gliomas: a biomarker discovery study

  2024cites this paper
• Cross‐modal integration of bulk RNA‐seq and single‐cell RNA sequencing data to reveal T‐cell exhaustion in colorectal cancer

  2024cites this paper
• Global analysis of T-cell groups reveals immunological features and common antigen targets of digestive tract tumors

  2024cites this paper
• Advances in vaccine development for cancer prevention and treatment in Lynch Syndrome.

  2023cites this paper
• Exosomal non-coding RNAs' role in immune regulation and potential therapeutic applications.

  2023cites this paper
• Strategies for overcoming bottlenecks in allogeneic CAR-T cell therapy

  2023cites this paper
• Microsatellite Instability and Immune Response: From Microenvironment Features to Therapeutic Actionability—Lessons from Colorectal Cancer

  2023cites this paper
• Lynch Syndrome: From Carcinogenesis to Prevention Interventions

  2022cites this paper
• pathways and

  2022cites this paper
• Regulation of the antigen presentation machinery in cancer and its implication for immune surveillance

  2022cites this paper
• Система HLA и рак

  2021cites this paper
• HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy

  2021cites this paper
• Targeting Neoepitopes to Treat Solid Malignancies: Immunosurgery

  2021cites this paper
• Distinct Molecular Mechanisms of Altered HLA Class II Expression in Malignant Melanoma

  2021cites this paper
• Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I–III small cell lung cancer

  2021cites this paper
• Current Advances and Trends in KRAS Targeted Therapies for Colorectal Cancer

  2021cites this paper
• HLA AND CANCER

  2021cites this paper
• Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma

  2020influential citation
• Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer

  2020cites this paper
• Fisetin inhibits proliferation of pancreatic adenocarcinoma by inducing DNA damage via RFXAP/KDM4A-dependent histone H3K36 demethylation

  2020cites this paper
• Implications of Hereditary Origin on the Immune Phenotype of Mismatch Repair-Deficient Cancers: Systematic Literature Review

  2020cites this paper
• Non-AIDS defining cancers: a comprehensive update on diagnosis and management.

  2020cites this paper
• TITLE: Lynch Syndrome – Cancer Pathways, Heterogeneity and Immune Escape RUNNING TITLE: Lynch syndrome cancer pathways and immune escape AUTHORS:

  2019cites this paper
• Biomarkers of mismatch repair deficiency in colorectal cancer and cancer predisposition syndromes

  2019influential citation
• Exosomes and pancreatic diseases: status, challenges, and hopes

  2019cites this paper
• Functions and clinical implications of exosomes in pancreatic cancer.

  2019cites this paper
• Lynch syndrome – cancer pathways, heterogeneity and immune escape

  2018cites this paper
• IFN-γ induces the upregulation of RFXAP via inhibition of miR-212-3p in pancreatic cancer cells: A novel mechanism for IFN-γ response.

  2018cites this paper
• High numbers of PDCD1 (PD-1)-positive T cells and B2M mutations in microsatellite-unstable colorectal cancer

  2018cites this paper
• Transfer of Allogeneic CD4+ T Cells Rescues CD8+ T Cells in Anti-PD-L1–Resistant Tumors Leading to Tumor Eradication

  2017cites this paper
• Genomic and transcriptomic heterogeneity of colorectal tumours arising in Lynch syndrome

  2017cites this paper
• HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance

  2017cites this paper
• CD4 and CD8 T lymphocyte interplay in controlling tumor growth

  2017cites this paper
• Spontaneous regression of transverse colon cancer: a case report

  2017cites this paper
• The Immune Biology of Microsatellite-Unstable Cancer.

  2016cites this paper
• Low density of FOXP3-positive T cells in normal colonic mucosa is related to the presence of beta2-microglobulin mutations in Lynch syndrome-associated colorectal cancer

  2016cites this paper
• Opportunities for immunotherapy in microsatellite instable colorectal cancer

  2016cites this paper
• Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p

  2015cites this paper
• Vaccination of MSI-H colorectal cancer patients with frameshift peptide antigens: A phase I/IIa clinical trial.

  2014cites this paper
• pathways and immune escape

  year unknowncites this paper
• HIV AND COLORECTAL CANCER. NEW INSIGHTS AND REVIEW OF THE LITERATURE

  year unknowncites this paper